Lawrence E. Bullock, Chief Financial Officer at BIOMIMETIC THERAPEUTICS, INC. (BMTI), bought 10,000 shares at $8.00 ($80K) on 2006-05-12, disclosed to the SEC on 2006-05-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| BMTI | BUY | 2009-04-01 | $41K | — | Filing → |
| BMTI | BUY | 2008-04-01 | $90K | — | Filing → |